News

The 2.25mm version of the Xience V stent will be launched immediately in the majority of European markets and select countries in Asia and Latin America. In addition

The study found that post-menopausal women who took the Novartis drug Femara for one to seven years after finishing a five-year regimen of tamoxifen reduced the risk of

Under the terms of the all-cash merger agreement Cytogen shareholders will receive $0.62 per share, representing a 35% premium on the company’s share price. To meet the acquisition

The Cotara clinical update covers the first cohort of patients in its dosimetry trial as well as experience to date in an ongoing Phase II safety and efficacy

The Tailor Flexible Ring and Band are designed to accommodate the natural movement of the annulus, and physicians can tailor the products to meet precise patient needs. The

In both qualitative and quantitative studies, 124 physicians board certified in obstetrics, gynecology and specializing in the treatment of menopause reported MF101, if approved, would be their drug

The premium brand yogurt will be distributed to major food retailers in Italy. Fiave has invested significant time and capital in advanced technology machinery and a state of

These findings revealed that almost 90% of patients treated with Carticel who experienced improvement in knee function at an early follow-up, sustained their improvement for up to almost

Under the first transaction, NuVasive has satisfied all remaining royalty obligations for its SpheRx platform of products for a single cash payment of $3.25 million. The transaction provides